17 October, 2024Noema Pharma Announces NOE-105 (gemlapodect) Phase 2a Study in Tourette Syndrome met Primary and all Key Secondary Endpoints
15 October, 2024Bio-engineering scale-up Qorium showcases cultivated leather breakthrough, signalling a key step towards commercialisation
9 October, 2024Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases